| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
149,418 |
293,719 |
402,743 |
782,338 |
| Total Sell Value |
$57,642,236 |
$111,244,170 |
$144,625,015 |
$240,103,649 |
| Total People Sold |
7 |
10 |
12 |
12 |
| Total Sell Transactions |
22 |
33 |
44 |
71 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2021-01-26 |
4 |
OE |
$170.76 |
$213,446 |
D/D |
1,250 |
5,318 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2021-01-26 |
4 |
AS |
$754.48 |
$1,886,200 |
D/D |
(2,500) |
7,839 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2021-01-26 |
4 |
OE |
$161.27 |
$403,167 |
D/D |
2,500 |
10,339 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2020-12-09 |
4 |
AS |
$758.34 |
$4,398,582 |
I/I |
(5,800) |
11,600 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2020-12-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
29,000 |
14,500 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2020-12-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
35,800 |
108,757 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2020-12-08 |
4 |
AS |
$761.76 |
$8,466,228 |
D/D |
(11,114) |
252,197 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2020-12-08 |
4 |
OE |
$168.41 |
$2,357,740 |
D/D |
14,000 |
263,311 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-12-07 |
4 |
AS |
$778.00 |
$316,646 |
D/D |
(407) |
207 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-12-07 |
4 |
OE |
$238.91 |
$182,350 |
D/D |
407 |
237 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2020-12-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,400 |
13,273 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2020-10-26 |
4 |
AS |
$715.28 |
$4,291,690 |
D/D |
(6,000) |
14,673 |
|
- |
|
| Mohr Marshall |
Executive VP & CFO |
• – – |
2020-10-26 |
4 |
OE |
$127.91 |
$767,460 |
D/D |
6,000 |
20,673 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-10-20 |
4 |
AS |
$736.12 |
$555,034 |
D/D |
(754) |
207 |
|
- |
|
| Samath Jamie |
SVP of Finance |
• – – |
2020-10-20 |
4 |
OE |
$238.91 |
$298,057 |
D/D |
754 |
385 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-10-20 |
4 |
AS |
$736.12 |
$644,105 |
D/D |
(875) |
2,986 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2020-10-20 |
4 |
OE |
$238.91 |
$209,049 |
D/D |
875 |
3,861 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-10-20 |
4 |
AS |
$736.12 |
$920,150 |
D/D |
(1,250) |
4,068 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-10-20 |
4 |
OE |
$170.76 |
$213,446 |
D/D |
1,250 |
5,318 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2020-10-20 |
4 |
AS |
$736.12 |
$1,325,016 |
D/D |
(1,800) |
7,839 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2020-10-20 |
4 |
OE |
$193.08 |
$347,544 |
D/D |
1,800 |
9,639 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-09-10 |
4 |
AS |
$718.50 |
$1,087,809 |
D/D |
(1,514) |
4,068 |
|
- |
|
| Andersen Reiter Kara |
Sr VP General Counsel & CCO |
• – – |
2020-09-10 |
4 |
OE |
$170.76 |
$213,446 |
D/D |
1,250 |
5,582 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2020-08-31 |
4 |
AS |
$723.73 |
$723,730 |
D/D |
(1,000) |
4,560 |
|
- |
|
| Rubash Mark J |
Director |
– • – |
2020-08-31 |
4 |
OE |
$193.08 |
$193,080 |
D/D |
1,000 |
5,560 |
|
- |
|
1324 Records found
|
|
Page 18 of 53 |
|
|
5.92 (1.56%) 
